Bridgebio Pharma Inc. buy BiotechBee
Start price
24.06.23
/
60%
€14.15
Target price
31.12.25
€30.00
Performance (%)
39.02%
End price
17.07.23
€19.67
Summary
This prediction ended on 17.07.23 with a price of €19.67. With a performance of 39.02% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Bridgebio Pharma Inc. where he still thinks Bridgebio Pharma Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bridgebio Pharma Inc. | - | - |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
According to BiotechBee what are the pros and cons of Bridgebio Pharma Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bridgebio Pharma Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Bridgebio Pharma Inc.
Buy beendet
Current prediction by BiotechBee for Bridgebio Pharma Inc.
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€24.00
29.10.23
29.10.23
€40.00
30.09.25
30.09.25
7.71%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Bridgebio Pharma Inc.
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€24.78
17.07.23
17.07.23
€50.00
31.10.25
31.10.25
-3.15%
29.10.23
29.10.23
Could be very worthwhile Investment >20% year
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€16.70
17.07.23
17.07.23
€40.00
17.07.24
17.07.24
59.58%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€11.00
07.09.22
07.09.22
€30.00
31.12.25
31.12.25
6.82%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year